University of California Davis Comprehensive Cancer Center — Sacramento, California

Public research footprint of University of California Davis Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

596

Registered studies

322

Active

114

Recruiting now

204

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia Arising From Previous… · Lung Non-Squamous Non-Small Cell Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IIIB Lung Cancer AJCC v8

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT05600894 — Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic… (Active Not Recruiting)
NCT00114101 — Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of California Davis Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.